BridgeBio Pharma, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
BridgeBio Pharma, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2018 to Q3 2024.
  • BridgeBio Pharma, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $20.3M, a 8.65% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $20.3M +$1.62M +8.65% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $18.9M -$1.5M -7.34% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $20.7M -$45K -0.22% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $22.6M +$2.4M +11.9% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $18.7M -$11.2M -37.5% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $20.4M -$10.9M -34.9% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $20.8M -$14.6M -41.2% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $20.2M -$12.8M -38.8% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $29.9M -$3.18M -9.63% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $31.3M -$18.5M -37.1% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $35.3M +$5.15M +17.1% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $33M +$9.1M +38% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $33.1M +$16.6M +101% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $49.8M +$32.5M +189% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $30.2M +$13.2M +77.3% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $23.9M -$2.36M -8.97% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $16.5M +$13.9M +534% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $17.3M Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $17M Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $26.3M +$25.2M +2305% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $2.6M Sep 30, 2019 10-Q 2019-11-08
Q4 2018 $1.09M Dec 31, 2018 10-K 2020-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.